# URO-BCG-4 : Bladder Tumors Immunotherapy

> **NCT00213655** · — · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 146 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **BIOLOGICAL:** bladder tumor recurrence

## Key facts

- **NCT ID:** NCT00213655
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-06
- **Primary completion:** 2013-05
- **Final completion:** 2013-12
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2014-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00213655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00213655, "URO-BCG-4 : Bladder Tumors Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00213655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*